Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study

---

Hsu C., Dziadziuszko R., Gomez Abreo D. A., Aksoy S., Gil Martin M., Roderburg C., ...Daha Fazla

ANNALS OF ONCOLOGY, 2024 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Özet
• Basım Tarihi: 2024
• Doi Numarası: 10.1016/j.annonc.2024.05.316
• Dergi Adı: ANNALS OF ONCOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, CAB Abstracts, EMBASE, MEDLINE
• Hacettepe Üniversitesi Adresli: Evet